252 related articles for article (PubMed ID: 22879971)
1. SPARC is a key regulator of proliferation, apoptosis and invasion in human ovarian cancer.
Chen J; Wang M; Xi B; Xue J; He D; Zhang J; Zhao Y
PLoS One; 2012; 7(8):e42413. PubMed ID: 22879971
[TBL] [Abstract][Full Text] [Related]
2. Targeting SPARC by lentivirus-mediated RNA interference inhibits cervical cancer cell growth and metastasis.
Chen J; Shi D; Liu X; Fang S; Zhang J; Zhao Y
BMC Cancer; 2012 Oct; 12():464. PubMed ID: 23050783
[TBL] [Abstract][Full Text] [Related]
3. SPARC suppresses lymph node metastasis by regulating the expression of VEGFs in ovarian carcinoma.
Peng F; Zhong Y; Liu Y; Zhang Y; Xie Y; Lu Y; Zhang X; Li D
Int J Oncol; 2017 Dec; 51(6):1920-1928. PubMed ID: 29075785
[TBL] [Abstract][Full Text] [Related]
4. SPARC silencing inhibits the growth of acute myeloid leukemia transformed from myelodysplastic syndrome via induction of cell cycle arrest and apoptosis.
Nian Q; Xiao Q; Wang L; Luo J; Chen LP; Yang ZS; Liu L
Int J Mol Med; 2014 Apr; 33(4):856-62. PubMed ID: 24535175
[TBL] [Abstract][Full Text] [Related]
5. Targeting HMGB1 inhibits ovarian cancer growth and metastasis by lentivirus-mediated RNA interference.
Chen J; Liu X; Zhang J; Zhao Y
J Cell Physiol; 2012 Nov; 227(11):3629-38. PubMed ID: 22331597
[TBL] [Abstract][Full Text] [Related]
6. SPARC expression is negatively correlated with clinicopathological factors of gastric cancer and inhibits malignancy of gastric cancer cells.
Zhang J; Wang P; Zhu J; Wang W; Yin J; Zhang C; Chen Z; Sun L; Wan Y; Wang X; Chen G; Liu Y
Oncol Rep; 2014 May; 31(5):2312-20. PubMed ID: 24676680
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Proliferation, Migration, and Invasion by Knockdown of Pyruvate Kinase-M2 (PKM2) in Ovarian Cancer SKOV3 and OVCAR3 Cells.
Miao Y; Lu M; Yan Q; Li S; Feng Y
Oncol Res; 2016 Oct; 24(6):463-475. PubMed ID: 28281967
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the bi-directional cross-talk between ovarian cancer cells and adipocytes by SPARC.
John B; Naczki C; Patel C; Ghoneum A; Qasem S; Salih Z; Said N
Oncogene; 2019 May; 38(22):4366-4383. PubMed ID: 30765860
[TBL] [Abstract][Full Text] [Related]
9. Secreted protein acidic and rich in cysteine promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells and acquisition of cancerstem cell phenotypes.
Jiang X; Liu F; Wang Y; Gao J
J Gastroenterol Hepatol; 2019 Oct; 34(10):1860-1868. PubMed ID: 31041810
[TBL] [Abstract][Full Text] [Related]
10. Absence of host-secreted protein acidic and rich in cysteine (SPARC) augments peritoneal ovarian carcinomatosis.
Said N; Motamed K
Am J Pathol; 2005 Dec; 167(6):1739-52. PubMed ID: 16314484
[TBL] [Abstract][Full Text] [Related]
11. SPARC (secreted protein acidic and rich in cysteine) induces apoptosis in ovarian cancer cells.
Yiu GK; Chan WY; Ng SW; Chan PS; Cheung KK; Berkowitz RS; Mok SC
Am J Pathol; 2001 Aug; 159(2):609-22. PubMed ID: 11485919
[TBL] [Abstract][Full Text] [Related]
12. SPARC, an extracellular matrix protein with tumor-suppressing activity in human ovarian epithelial cells.
Mok SC; Chan WY; Wong KK; Muto MG; Berkowitz RS
Oncogene; 1996 May; 12(9):1895-901. PubMed ID: 8649850
[TBL] [Abstract][Full Text] [Related]
13. Secreted protein acidic and rich in cysteine (SPARC) inhibits integrin-mediated adhesion and growth factor-dependent survival signaling in ovarian cancer.
Said N; Najwer I; Motamed K
Am J Pathol; 2007 Mar; 170(3):1054-63. PubMed ID: 17322388
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of SPARC expression inhibits the invasion of human trophoblast cells in vitro.
Jiang Y; Zhu Y; Shi Y; He Y; Kuang Z; Sun Z; Wang J
PLoS One; 2013; 8(7):e69079. PubMed ID: 23935929
[TBL] [Abstract][Full Text] [Related]
15. Activation of SPARC expression in reactive stroma associated with human epithelial ovarian cancer.
Brown TJ; Shaw PA; Karp X; Huynh MH; Begley H; Ringuette MJ
Gynecol Oncol; 1999 Oct; 75(1):25-33. PubMed ID: 10502421
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of SPARC expression decreases gastric cancer cellular invasion and survival.
Yin J; Chen G; Liu Y; Liu S; Wang P; Wan Y; Wang X; Zhu J; Gao H
J Exp Clin Cancer Res; 2010 Jun; 29(1):59. PubMed ID: 20525171
[TBL] [Abstract][Full Text] [Related]
17. SPARC mediates Src-induced disruption of actin cytoskeleton via inactivation of small GTPases Rho-Rac-Cdc42.
Bhoopathi P; Gondi CS; Gujrati M; Dinh DH; Lakka SS
Cell Signal; 2011 Dec; 23(12):1978-87. PubMed ID: 21798346
[TBL] [Abstract][Full Text] [Related]
18. Secreted Protein Acidic and Rich in Cysteine (SPARC) Enhances Cell Proliferation, Migration, and Epithelial Mesenchymal Transition, and SPARC Expression is Associated with Tumor Grade in Head and Neck Cancer.
Chang CH; Yen MC; Liao SH; Hsu YL; Lai CS; Chang KP; Hsu YL
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28718842
[TBL] [Abstract][Full Text] [Related]
19. KLF4 inhibition of lung cancer cell invasion by suppression of SPARC expression.
Zhou Y; Hofstetter WL; He Y; Hu W; Pataer A; Wang L; Wang J; Zhou Y; Yu L; Fang B; Swisher SG
Cancer Biol Ther; 2010 Apr; 9(7):507-13. PubMed ID: 20215880
[TBL] [Abstract][Full Text] [Related]
20. The p53/p21Cip1/ Waf1 pathway mediates the effects of SPARC on melanoma cell cycle progression.
Fenouille N; Robert G; Tichet M; Puissant A; Dufies M; Rocchi S; Ortonne JP; Deckert M; Ballotti R; Tartare-Deckert S
Pigment Cell Melanoma Res; 2011 Feb; 24(1):219-32. PubMed ID: 20955243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
